Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology | Immunology
 Disease Category: Lymphoma
Location: United States, CA

Trial Information

Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial

You have been asked to participate in this research study because you are a woman who was diagnosed with cancer more than two years ago and your treatment included radiation therapy to your chest. The purpose of this study is to determine whether two years of low dose tamoxifen has an effect on laboratory tests and other evaluations associated with the risk of breast cancer in female cancer survivors treated with chest radiation at a young age. Another purpose is to measure the safety and tolerability of tamoxifen according to laboratory tests and information on side effects collected from questionnaires. Your participation in this study is expected to last about two years.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.